High androgen receptor immunoexpression in human "Sertoli cell only" testis. 2005

L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
Laboratoire de Génétique Moléculaire Humaine, Faculté de Mèdecine, Sfax, Tunisie.

Our purpose was to evaluate cellular androgen receptor (AR) distribution and intensity of immunostaining in the human azoospermic testis. Thirty six biopsy specimens from azoospermic men were immunostained, using a monoclonal antibody of human AR. The localization and the intensity of AR immunostaining was evaluated in Sertoli Cell Only (SCO) testis (G1, n = 21), in spermatogenesis arrest testis (G2, n = 11) and in histologically normal testis (G3, n = 4). We found an AR immunostaining in Sertoli, peritubular myoid and Leydig cells, but not in germ cells. The intensity of the immunostaining varied substantially between biopsy specimens of different patients. Sertoli and Leydig cells AR immunostaining (score and intensity) in SCO group was higher than in the other groups. For Sertoli cells, the score means of AR immunoreactivity were 20 +/- 2.36, 10.18 +/- 1.0 and 1 +/- 1, for G1, G2 and G3 groups, respectively. For Leydig cells, the score means were 10.24 +/- 1.37, 6 +/- 0.71 and 0, for G1, G2 and G3 groups, respectively. We found significant differences between G1 and G2 (p = 0.0008), between G1 and G3 (p = 1.54 10-7) and G2 and G3 (p = 0.00032). These results suggest that in the testis AR is located exclusively in somatic cells and its expression is higher in SCO syndrome than in normal and in arrest spermatogenesis testes.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007985 Leydig Cells Steroid-producing cells in the interstitial tissue of the TESTIS. They are under the regulation of PITUITARY HORMONES; LUTEINIZING HORMONE; or interstitial cell-stimulating hormone. TESTOSTERONE is the major androgen (ANDROGENS) produced. Interstitial Cells, Testicular,Leydig Cell,Testicular Interstitial Cell,Testicular Interstitial Cells,Cell, Leydig,Cell, Testicular Interstitial,Cells, Leydig,Cells, Testicular Interstitial,Interstitial Cell, Testicular
D008297 Male Males
D009845 Oligospermia A condition of suboptimal concentration of SPERMATOZOA in the ejaculated SEMEN to ensure successful FERTILIZATION of an OVUM. In humans, oligospermia is defined as a sperm count below 20 million per milliliter semen. Cryptospermia,Cryptozoospermia,Low Sperm Count,Hypospermatogenesis,Oligoasthenoteratozoospermia,Oligozoospermia,Cryptospermias,Cryptozoospermias,Hypospermatogeneses,Low Sperm Counts,Oligoasthenoteratozoospermias,Sperm Count, Low,Sperm Counts, Low
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012708 Sertoli Cells Supporting cells projecting inward from the basement membrane of SEMINIFEROUS TUBULES. They surround and nourish the developing male germ cells and secrete the ANDROGEN-BINDING PROTEIN and hormones such as ANTI-MULLERIAN HORMONE. The tight junctions of Sertoli cells with the SPERMATOGONIA and SPERMATOCYTES provide a BLOOD-TESTIS BARRIER. Sertoli Cell,Cell, Sertoli,Cells, Sertoli
D013091 Spermatogenesis The process of germ cell development in the male from the primordial germ cells, through SPERMATOGONIA; SPERMATOCYTES; SPERMATIDS; to the mature haploid SPERMATOZOA. Spermatocytogenesis,Spermiogenesis

Related Publications

L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
July 1977, Endocrinology,
L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
January 1988, Annals of the New York Academy of Sciences,
L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
July 1999, Histology and histopathology,
L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
January 1999, The Journal of clinical endocrinology and metabolism,
L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
December 1994, International journal of andrology,
L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
April 2015, Biology of reproduction,
L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
January 2001, The Journal of clinical endocrinology and metabolism,
L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
January 1975, Current topics in molecular endocrinology,
L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
October 2014, Medical science monitor : international medical journal of experimental and clinical research,
L Hadjkacem Loukil, and T Sellami Boudawara, and I Ayadi, and A Bahloul, and R Jlidi, and H Ayadi, and L Ammar Keskes
November 1984, American journal of obstetrics and gynecology,
Copied contents to your clipboard!